Home-Page-Slides-Images_1.jpg

The RIGHT Treatment

The FIRST Time

Powered by the PREDICTIX Artificial Intelligence Mental Health Platform

630M

People globally suffer with mental health disorders

No.1

Depression is the leading cause of disability worldwide

65%

of patients will not achieve complete relief from their first medication

Advancing the Treatment of Mental Health

Advancing the Treatment of Mental Health

Today, global annual costs for mental health have reached $25 trillion, led by depression.  Yet, the right antidepressant is only prescribed in about 50% of cases. This leaves patients to face a painful and costly 6-18 months trialling different antidepressants. 

PREDICTIX harnesses AI to empower clinician precision prescribing decisions for a faster patient recovery.

Mental health conditions are highly complex and affect each of us uniquely. Their successful treatment depends on understanding the relationships between patients’ genetic, metabolic, demographic and clinical information. 

The PREDICTIX mental health platform uses AI to translate this complex data into an easy-to-use assessment and validation software to empower patient prescribing decisions and follow-up.

Software Empowering Mental Health

Prescribing Decisions

and Follow-up

WE WORK WITH

Partner With Us

Telemedicine
Healthcare Distributors
DNA Laboratories
Payers and Providers
CONTACT US

Tel: +972 (0)77 335 2506

Fax: +972 (0)3 650 5594

office@taliazhealth.com

2 Prof. Yehezkel Kaufmann St.

(15th Floor), Tel Aviv-Yafo, Israel

  • LinkedIn
  • Twitter
  • Facebook
PREDICTIX_Logo_Dark.png

Disclaimer: Taliaz is developing the PREDICTIX Genetics and PREDICTIX Digital products. PREDICTIX Genetics Antidepressant and PREDICTIX Digital Antidepressant are currently available for commercial use in the EU and Israel. Outside of the EU and Israel, PREDICTIX Genetics & Digital products are currently limited by law for investigational use only.

Copyright © 2020 PREDICTIX by TALIAZ Ltd. All Rights Reserved